These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18779377)

  • 1. Population pharmacokinetics of tenofovir in AIDS patients.
    Gagnieu MC; Barkil ME; Livrozet JM; Cotte L; Miailhes P; Boibieux A; Guitton J; Tod M
    J Clin Pharmacol; 2008 Nov; 48(11):1282-8. PubMed ID: 18779377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP; Mathias A
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
    Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK
    J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen.
    Lowe SH; van Leeuwen E; Droste JA; van der Veen F; Reiss P; Lange JM; Burger DM; Repping S; Prins JM
    Ther Drug Monit; 2007 Oct; 29(5):566-70. PubMed ID: 17898645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques.
    Van Rompay KK; Hamilton M; Kearney B; Bischofberger N
    Antimicrob Agents Chemother; 2005 May; 49(5):2093-4. PubMed ID: 15855535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of modelling intra-subject variability on tests based on non-linear mixed-effects models in cross-over pharmacokinetic trials with application to the interaction of tenofovir on atazanavir in HIV patients.
    Panhard X; Taburet AM; Piketti C; Mentré F
    Stat Med; 2007 Mar; 26(6):1268-84. PubMed ID: 16810714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects.
    Ramanathan S; Cheng A; Mittan A; Ebrahimi R; Kearney BP
    J Clin Pharmacol; 2006 May; 46(5):559-66. PubMed ID: 16638739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of albendazole in patients with neurocysticercosis.
    Castro N; Márquez-Caraveo C; Brundage RC; González-Esquivel D; Suárez AM; Góngora F; Jara A; Urizar J; Lanao JM; Jung H
    Int J Clin Pharmacol Ther; 2009 Nov; 47(11):679-85. PubMed ID: 19840532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).
    Hirt D; Urien S; Ekouévi DK; Rey E; Arrivé E; Blanche S; Amani-Bosse C; Nerrienet E; Gray G; Kone M; Leang SK; McIntyre J; Dabis F; Tréluyer JM;
    Clin Pharmacol Ther; 2009 Feb; 85(2):182-9. PubMed ID: 18987623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.
    Solas C; Gagnieu MC; Ravaux I; Drogoul MP; Lafeuillade A; Mokhtari S; Lacarelle B; Simon N
    Ther Drug Monit; 2008 Dec; 30(6):670-3. PubMed ID: 18806695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
    Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
    AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin population pharmacokinetic analysis in hospitalized patients.
    Soy D; López E; Ribas J
    Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failure.
    Ter Heine R; Huitema AD; Jansen RS; Smits PH; van Gorp EC; Wagenaar JF; Beijnen JH; Mulder JW
    Antivir Ther; 2009; 14(2):299-301. PubMed ID: 19430105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic study of cyclosporine in patients with nephrotic syndrome.
    Xiaoli D; Qiang F
    J Clin Pharmacol; 2009 Jul; 49(7):782-8. PubMed ID: 19448042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic investigation of low-dose methotrexate in rheumatoid arthritics Japanese patients.
    Yukawa E; Mori S; Ueda K; Nakada Y
    J Clin Pharm Ther; 2007 Dec; 32(6):573-8. PubMed ID: 18021334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic model of carbamazepine derived from routine therapeutic drug monitoring data.
    Vucićević K; Miljković B; Velicković R; Pokrajac M; Mrhar A; Grabnar I
    Ther Drug Monit; 2007 Dec; 29(6):781-8. PubMed ID: 18043476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study.
    Guaraldi G; Roverato A; Giovanardi C; Ravera F; Squillace N; Orlando G; Cappelli G; Esposito R; Palella F
    J Antimicrob Chemother; 2009 Feb; 63(2):374-9. PubMed ID: 19095683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.